Teva Pharmaceutical Industries (TEVA) Change in Inventory (2025 - 2026)

Teva Pharmaceutical Industries (TEVA) recorded quarterly Change in Inventory of -$93.0 million in Q1 2026, up 22.5% on a QoQ basis from -$120.0 million in Q1 2025, and up 22.5% year-over-year from -$75.9 million in Q1 2025.

Teva Pharmaceutical Industries (TEVA) Change in Inventory (2025 - 2026) Analysis & Trends

Teva Pharmaceutical Industries has disclosed Change in Inventory across 2 years of filings, most recently posting -$93.0 million for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Teva Pharmaceutical Industries 39.52 Bn 35.79 Bn 1.97 Bn -93.00 Mn
2 Zoetis 33.53 Bn 31.59 Bn 1.62 Bn 114.00 Mn
3 United Therapeutics 23.92 Bn 21.77 Bn 648.10 Mn 40.10 Mn
4 Aurora Cannabis 16.96 Bn 16.88 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.47 Bn 15.15 Bn 800.70 Mn -4.30 Mn
6 Elanco Animal Health 11.76 Bn 11.33 Bn 785.00 Mn -
7 Alkermes 7.11 Bn 6.60 Bn -116.06 Mn 6.43 Mn
8 Lantheus Holdings 6.53 Bn 6.03 Bn 230.92 Mn -2.11 Mn
9 Hims & Hers Health 5.98 Bn 5.23 Bn 396.79 Mn 20.30 Mn
10 Liquidia 5.44 Bn 5.22 Bn 121.79 Mn 4.57 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -93.00 Mn
Mar 31, 2026 -93.00 Mn
Mar 31, 2025 -120.00 Mn
Mar 31, 2025 -120.00 Mn